India’s health minister said a locally-developed COVID-19 vaccine candidate could complete its final trials in a month or two, raising hopes for a rapid rollout in a country with the world’s second highest number of infections.
Researchers at Karolinska Institutet in Sweden have studied the incidence and regional distribution of Alzheimer's disease biomarkers in the brains of people with Down's syndrome. The results can bring new possibilities for earlier diagnosis and preventive treatment of dementia. The study is published in Molecular Neurodegeneration.
US health care workers and others recommended for the nation’s first COVID-19 inoculations could start getting shots within a day or two of regulatory consent next month, a top official of the government’s vaccine development effort said.